Double-stranded RNA stimulation or CD40 ligation of monocyte-derived dendritic cells as models to study their activation and maturation process

European Cytokine Network

Volumn 15, Issue 2, 2004, Pages 126-134

  Megiovanni, Anna Maria ^a   Sanchez, Françoise ^a   Gluckman, Jean Claude ^a   Rosenzwajg, Michelle ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

Cell activation; Cell maturation; Cytokines; Dendritic cells; Human immunodeficiency virus

Indexed keywords

CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; DOUBLE STRANDED RNA; GLYCOPROTEIN GP 120; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LIGATION; PHENOTYPE; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 3242766865     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18: 767.
2. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28: 2760.
3. Reid SD, Penna G, Adorini L. 2000. The control of T cell responses by dendritic cell subsets. Curr Opin Immunol 12: 114.
4. Moser M, Murphy KM. 2000. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1: 199.
5. Langenkamp A, Casorati G, Garavaglia C, Dellabona P, Lanzavecchia A, Sallusto F. 2002. T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur J Immunol 32: 2046.
6. Gallucci S, Matzinger P. 2001. Danger signals: SOS to the immune system. Curr Opin Immunol 13: 114.
7. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732.
8. Vidalain PO, Azocar O, Yagita H, Rabourdin-Combe C, Servet-Delprat C. 2001. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. J Immunol 167: 3765.
9. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184: 747.
10. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587.
11. Canque B, Bakri Y, Camus S, Yagello M, Benjouad A, Gluckman JC. 1999. The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34(+) hematopoietic progenitor cells is primarily determined by their maturation stage. Blood 93: 3866.
12. Bakri Y, Schiffer C, Zennou V, Charneau P, Kahn E, Benjouad A, Gluckman JC, Canque B. 2001. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J Immunol 166: 3780.
13. Turville SG, Arthos J, Donald KM, Lynch G, Naif H, Clark G, Hart D, Cunningham AL. 2001. HIV gp120 receptors on human dendritic cells. Blood 98: 2482.
14. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. 1997. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27: 431.
15. Benkirane M, Hirn M, Carriere D, Devaux C. 1995. Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J Virol 69: 6898.
16. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109.
17. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 189: 821.
18. Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJ, Brand A, Goulmy E. 1999. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 163: 57.
19. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. 1998. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 160:4587.
20. Rosenzwajg M, Jourquin F, Tailleux L, Gluckman JC. 2002. CD40 ligation and phagocytosis differently affect the differentiation of monocytes into dendritic cells. J Leukoc Biol 72: 1180.
21. + cell-derived CD1a + CD14- and CD1a-CD14 + dendritic cell precursors in vitro. J Leukoc Biol 64: 235.
22. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121.
23. Vulcano M, Albanesi C, Stoppacciaro A, Bagnati R, D'Amico G, Struyf S, Transidico P, Bonecchi R, Del Prete A, Allavena P, Ruco LP, Chiabrando C, Girolomoni G, Mantovani A, Sozzani S. 2001. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 31: 812.
24. Lutz MB, Schuler G. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23: 445.
25. McDougal JS, Klatzmann DR, Maddon PJ. 1991. CD4-gp120 interactions. Curr Opin Immunol 3: 552.
26. Moore JP, Trkola A, Dragic T. 1997. Co-receptors for HIV-1 entry. Curr Opin Immunol 9: 551.
27. Berger EA, Murphy PM, Farber JM. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657.
28. + T cells. J Immunol 154: 5071.
29. Hilkens CM, Kalinski P, de Boer M, Kapsenberg ML. 1997. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90: 1920.
30. Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 20: 561.
31. Buelens C, Willems F, Delvaux A, Pierard G, Delville JP, Velu T, Goldman M. 1995. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 25: 2668.
32. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. 1997. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159: 4772.
33. Reis e Sousa C, Yap G, Schulz O, Rogers N, Schito M, Aliberti J, Hieny S, Sher A. 1999. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11: 637.
34. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M, Lanzavecchia A. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29: 1617.
35. Fong L, Mengozzi M, Abbey NW, Herndier BG, Engleman EG. 2002. Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J Virol 76: 11033.
36. + T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells. J Immunol 170: 4260.
37. + T cells. Science 257: 383.
38. Pope M, Betjes MG, Romani N, Hirmand H, Cameron PU, Hoffman L, Gezelter S, Schuler G, Steinman RM. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78: 389.
39. Canque B, Rosenzwajg M, Camus S, Yagello M, Bonnet ML, Guigon M, Gluckman JC. 1996. The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function. Blood 88: 4215.
40. Knight SC, Patterson S. 1997. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. Annu Rev Immunol 15: 593.
41. Zaitseva M, Blauvelt A, Lee S, Lapham CK, Klaus-Kovtun V, Mostowski H, Manischewitz J, Golding H. 1997. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat Med 3: 1369.